￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

medicaldrugs

Upadatinib/Reif achieves positive phase 3 results in non-segmental vitiligo

2026-02-01 22:25:32

Check Details
Bimetinib/Bemetinib Indications Scope

2026-02-01 22:25:32

Check Details
Analyze whether Teclistamab has been officially launched

2026-02-01 22:25:32

Check Details
Which company’s drug information is Quizartinib?

2026-02-01 22:25:32

Check Details
BCMA triple therapy (mabelantumab/pomalidomide/dexamethasone) shows deep response in multiple myeloma

2026-02-01 22:25:32

Check Details
Clinical application of aprocitentan in chronic thromboembolic pulmonary hypertension

2026-02-01 22:25:32

Check Details
Dietary precautions and contraindications while taking Tilpotide/Tisiparatide (Mufengda)

2026-02-01 22:25:32

Check Details
Pitobrutinib/Pirtobrutinib approval status and official approval instructions in China

2026-02-01 22:25:32

Check Details
Reasons for the ban on sales of Talazoparib and interpretation of relevant safety warnings

2026-02-01 22:25:32

Check Details
Comprehensive introduction and clinical application guidelines for Crizotinib (Xalkori)

2026-02-01 22:25:32

Check Details
Possible health risks and treatment methods of aprocitentan overdose

2026-02-01 22:25:32

Check Details
Tirpotide/Tirzepatide research and development background and clinical trial cutting-edge information

2026-02-01 22:25:32

Check Details
Category
相关知识